Venus Remedies Limited (BOM:526953)
881.65
+16.75 (1.94%)
At close: Mar 25, 2026
Venus Remedies Market Cap
Venus Remedies has a market cap or net worth of 11.62 billion as of March 27, 2026. Its market cap has increased by 196.10% in one year.
Market Cap
11.62B
Enterprise Value
9.40B
Revenue
7.03B
Ranking
n/a
PE Ratio
15.22
Stock Price
881.65
Market Cap Chart
Since October 19, 2004, Venus Remedies's market cap has increased from 242.83M to 11.62B, an increase of 4,683.78%. That is a compound annual growth rate of 19.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2026 | 11.79B | 14.95% |
| Dec 31, 2025 | 10.25B | 139.58% |
| Dec 31, 2024 | 4.28B | -21.14% |
| Dec 29, 2023 | 5.43B | 124.10% |
| Dec 30, 2022 | 2.42B | -55.77% |
| Dec 31, 2021 | 5.48B | 194.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hikal | 19.97B |
| Kwality Pharmaceuticals | 15.19B |
| Amrutanjan Health Care | 14.94B |
| Shukra Pharmaceuticals | 14.91B |
| Lincoln Pharmaceuticals | 11.87B |
| TTK Healthcare | 11.05B |
| Syncom Formulations (India) | 10.70B |
| Fermenta Biotech | 10.57B |